Literature DB >> 18718724

Impact of glucocorticoids and chronic stress on progression of Parkinson's disease.

Aleksandar Kibel1, Ines Drenjancević-Perić.   

Abstract

Parkinson's disease, a chronic progressive neurodegenerative disorder, has a mainly unknown multifactorial etiology. It is characterized by progressive degeneration of dopaminergic neurons. Chronic stress, a condition mediated by elevated concentrations of glucocorticoids over an extended period of time, has been shown to be unfavourable for neurons and to cause damage and neuronal loss in certain brain areas. Glucocorticoids are most probably not toxic in a direct manner, but can make neuronal damage through several potential indirect mechanisms in combination with other destructive factors. We postulate that chronic stress will have a harmful effect on patients with Parkinson's disease, facilitating neuronal degeneration and accelerating progression of clinical manifestations. The damaging impact on neurons will not be because of direct cytotoxicity, but by putting them into an energetically unfavourable condition, in which they will be more sensitive to destructive factors caused by the primary process. Possible mechanisms include elevation of excitatory amino acid concentration, which are excitotoxic, disruption of calcium homeostasis, metabolic disturbance or impairment of neurogenesis. This could have significant implications for patients with Parkinson's disease and chronic stress, or patients with glucocorticoid treatment for various immunopathological diseases, as well as patients with abnormal secretion of glucocorticoids such as in Cushing's syndrome. If confirmed, this hypothesis would represent a valuable advancement in care of patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718724     DOI: 10.1016/j.mehy.2008.06.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

Review 1.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

2.  Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats.

Authors:  Musa Vuyisile Mabandla; Vivienne Ann Russell
Journal:  Behav Brain Res       Date:  2010-03-03       Impact factor: 3.332

Review 3.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Changes in corticosteroid hormone receptors in the ischemic gerbil hippocampal CA1 region following repeated restraint stress.

Authors:  Ki-Yeon Yoo; Choong Hyun Lee; Jung Hoon Choi; Youdong Sohn; Jun Hwi Cho; In Koo Hwang; Young-Myeong Kim; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

Review 5.  Gestational restraint stress and the developing dopaminergic system: an overview.

Authors:  Carlos J Baier; María R Katunar; Ezequiela Adrover; María Eugenia Pallarés; Marta C Antonelli
Journal:  Neurotox Res       Date:  2012-01-04       Impact factor: 3.911

6.  A systems approach identifies networks and genes linking sleep and stress: implications for neuropsychiatric disorders.

Authors:  Peng Jiang; Joseph R Scarpa; Karrie Fitzpatrick; Bojan Losic; Vance D Gao; Ke Hao; Keith C Summa; He S Yang; Bin Zhang; Ravi Allada; Martha H Vitaterna; Fred W Turek; Andrew Kasarskis
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

7.  Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Authors:  Nayron Medeiros Soares; Gabriela Magalhães Pereira; Vivian Altmann; Rosa Maria Martins de Almeida; Carlos R M Rieder
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

8.  Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease.

Authors:  E Lauretti; A Di Meco; S Merali; D Praticò
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

9.  Covariation between plasma phosphate and daytime cortisol in early Parkinson's disease.

Authors:  Lena Håglin; Lennart Bäckman
Journal:  Brain Behav       Date:  2016-10-03       Impact factor: 2.708

10.  Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity.

Authors:  Chris Rudyk; Darcy Litteljohn; Shuaib Syed; Zach Dwyer; Shawn Hayley
Journal:  Neurobiol Stress       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.